"Ecstasy" induced immunosuppression and herpes zoster ophthalmicus [6]

British Journal of Ophthalmology

Volumn 89, Issue 7, 2005, Pages 923-924

  Zwick, Orin M ^a,c   Fischer, D H ^b   Flanagan, J C ^b  

^a UCSF Department of Ophthalmology   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c Department of Ophthalmology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACICLOVIR;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG ABUSE; DRUG DEPENDENCE; DRUG INDUCED DISEASE; FEMALE; HERPES ZOSTER OPHTHALMICUS; HUMAN; IMMUNE DEFICIENCY; IMMUNE FUNCTION TEST; LETTER; LYMPHOCYTE PROLIFERATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

ADULT; HALLUCINOGENS; HERPES ZOSTER OPHTHALMICUS; HUMANS; IMMUNE TOLERANCE; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE;

EID: 21344433430     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.061150     Document Type: Letter

References (10)

1. Connor TJ, McNamara MG, Finn D, et al. Acute 3,4- methylenedloxymethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology 1998;38:253-60.
2. Pacifici R, Zuccaro P, Lopez H, et al. Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. J Pharmacol Exp Ther 2001;296:207-15.
3. Connor TJ. Methylenedioxymethamphetamine (MDMA, "Ecstasy"): a stressor on the immune system. Immunology 2004;111:357-67.
4. Connor TJ, Kelly JP, Leonard BE. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology 2000;46:223-35.
5. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002;347:340-6.
6. Peroutka SJ. Incidence of recreational use of 3,4- methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus. N Engl J Med 1987;317:1542-3.
7. Koesters SC, Rogers PD, Rajasingham CR. MDMA ("ecstasy") and other "club drugs": the new epidemic. Pediatr Clin North Am 2002;49:415-33.
8. Burgess C, O'Donohoe A, Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur Psychiatry 2000;15:287-94.
9. Qasim A, Townend J, Davies MK. Ecstasy induced acute myocardial infarction. Heart 2001;85:e10.
10. Duflou J, Mark A. Aortic dissection after ingestion of "ecstasy" (MDMA). Am J Forensic Med Pathol 2000;21:261-3.